Literature DB >> 18814251

Tissue persistence of parvovirus B19 genotypes in asymptomatic persons.

Fabiana Corcioli1, Krystyna Zakrzewska, Alessio Rinieri, Rosa Fanci, Massimo Innocenti, Roberto Civinini, Vincenzo De Giorgi, Simonetta Di Lollo, Alberta Azzi.   

Abstract

Parvovirus B19 (B19V) can persist in immunocompetent symptomatic and non-symptomatic individuals, as demonstrated by the finding of viral DNA in different tissues, in absence of viremia and of anti-B19V IgM. The spread and the nature of this phenomenon have not been clearly determined. In order to investigate the frequency of persistence and the tissue distribution of the three genotypes of B19V, the viral load of the persistent virus and its expression in the affected tissues, 139 tissue samples and 102 sera from 139 asymptomatic individuals have been analyzed by consensus PCRs and genotype specific PCRs for B19V detection and genotyping. Viral load was measured by real time PCR and viral mRNAs were detected by RT-PCR. Altogether, 51% individuals carried B19V DNA, more frequently in solid tissues (65%) than in bone marrow (20%). Genotype 1 was found in 28% tissue samples, genotype 2 in 68% and genotype 3 in 3% only. Viral load ranged from less then 10 copies to 7 x 10(4) copies per 10(6) cells, with the exception of two samples of myocardium with about 10(6) copies per 10(6) cells. mRNA of capsid proteins was present in two bone marrow samples only. In conclusion, in asymptomatic individuals B19V persistence is more common in solid tissues than in bone marrow, and genotype 2 persists more frequently than genotype 1. The results suggest that the virus persists without replicating, at sub-immunogenic levels. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18814251     DOI: 10.1002/jmv.21289

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  28 in total

1.  Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure.

Authors:  Garrick C Stewart; Javier Lopez-Molina; Raju V S R K Gottumukkala; Gregg F Rosner; Mary S Anello; Jonathan L Hecht; Gayle L Winters; Robert F Padera; Kenneth L Baughman; Myra A Lipes
Journal:  Circ Heart Fail       Date:  2010-11-19       Impact factor: 8.790

2.  Prevalence and Viral Load of Human Parvovirus B19 (B19V) Among Blood Donors in South-East Brazil.

Authors:  Svetoslav Nanev Slavov; Katia Kaori Otaguiri; Dimas Tadeu Covas; Simone Kashima
Journal:  Indian J Hematol Blood Transfus       Date:  2015-10-19       Impact factor: 0.900

3.  Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis.

Authors:  Christian Ukena; Michael Kindermann; Felix Mahfoud; Jürgen Geisel; Philipp M Lepper; Reinhard Kandolf; Michael Böhm; Ingrid Kindermann
Journal:  Clin Res Cardiol       Date:  2014-04-30       Impact factor: 5.460

Review 4.  Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection.

Authors:  Toshitaka Yajima
Journal:  Future Microbiol       Date:  2011-05       Impact factor: 3.165

Review 5.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  Gender differences in the relationship of anti-parvovirus B19 IgG with antinuclear antibody and C-reactive protein in clinical adult serum samples.

Authors:  Thomas A O'Bryan; Stanley J Naides
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

7.  Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture.

Authors:  Violetta Kivovich; Leona Gilbert; Matti Vuento; Stanley J Naides
Journal:  Int J Med Sci       Date:  2010-05-25       Impact factor: 3.738

Review 8.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

9.  Adenovirus death protein (ADP) is required for lytic infection of human lymphocytes.

Authors:  V K Murali; D A Ornelles; L R Gooding; H T Wilms; W Huang; A E Tollefson; W S M Wold; C Garnett-Benson
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

10.  The Human Bone Marrow Is Host to the DNAs of Several Viruses.

Authors:  Mari Toppinen; Antti Sajantila; Diogo Pratas; Klaus Hedman; Maria F Perdomo
Journal:  Front Cell Infect Microbiol       Date:  2021-04-22       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.